Inside the desperate effort to keep healthcare alive on Ukraine’s front line 15/08/2023 Lily Hyde Russia’s war has had a devastating impact on healthcare provision in Ukraine. The World Health Organization (WHO) has recorded more than 1,100 attacks on its healthcare system since the invasion began on 24 February 2022, and more than one in 10 Ukrainian hospitals have been directly damaged by the war.In some areas occupied by Russia, […] Continue reading -> Chile’s Comprehensive Food Policy Offers Global Lesson in Tackling Unhealthy Foods 08/08/2023 Francesca R Dillman Carpentier, Lindsey Smith Taillie & Teresa Correa Ultra-processed products are usurping healthier, minimally processed foods in much of the world. Breakfasts are too often pre-packaged and sugar-laden, while lunches are loaded with sodium and wrapped in plastic – products that have been transformed using industrial processes and filled with additives to make them highly palatable. The widespread consumption of these foods and […] Continue reading -> Are The Three Pandemic Negotiations Bringing a Safer World Closer? 31/07/2023 Kerry Cullinan While July saw a crush of global pandemic-related meetings – some joint and some clashing – to accommodate tight schedules and northern summer holidays, achieving a pandemic-proof world is still a long way off. The two pandemic negotiations underway at the World Health Organization (WHO) have held individual and joint meetings over the past few […] Continue reading -> While Anti-Smoking Policies Cover 70% of Global Population, Taxation is Under-Utilised 31/07/2023 Elaine Ruth Fletcher Some 5.6 billion people – 71% of the world’s population – are now covered by at least one tobacco protection policy adopted by their national governments, according to a new World Health Organization (WHO) report published today. That is five times more people than were protected in 2007, when the comprehensive set of anti-smoking policies, […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> A ‘New Era’: Drug Slows Alzheimer’s Progression By One-Third 18/07/2023 Stefan Anderson For the second time this year, a new drug showed that the cognitive decline caused by Alzheimer’s disease – the leading cause of dementia worldwide that affects an estimated 55 million people – can be slowed down. Clinical trial results for donanemab, presented to the Alzheimer’s Association International Conference on Monday, showed the antibody medicine […] Continue reading -> Unite, Act, Eliminate: Mobilising Africa’s Response Against Neglected Tropical Diseases 14/07/2023 Umaro Sissoco Embaló African leaders must take the lead in the fight against Neglected Tropical Diseases, invest in their control and elimination, and foster cross-border collaboration to achieve the goal of eliminating NTDs as public health concerns by 2030. Neglected Tropical Diseases (NTDs) continue to pose a significant threat to the health and well-being of millions of people […] Continue reading -> Aspartame Linked to Liver Cancer but Evidence ‘Limited’: New Findings by International Cancer Agency 14/07/2023 Kerry Cullinan In groundbreaking new research, experts at the International Agency for Research on Cancer (IARC) have raised a cautious red flag about the artificial sweetener, aspartame, and its link to liver cancer, but stress that evidence is “limited”. IARC’s Dr Mary Schubauer-Berigan described the artificial sweetener as “possibly carcinogenic to humans” based on “limited evidence” of […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Chile’s Comprehensive Food Policy Offers Global Lesson in Tackling Unhealthy Foods 08/08/2023 Francesca R Dillman Carpentier, Lindsey Smith Taillie & Teresa Correa Ultra-processed products are usurping healthier, minimally processed foods in much of the world. Breakfasts are too often pre-packaged and sugar-laden, while lunches are loaded with sodium and wrapped in plastic – products that have been transformed using industrial processes and filled with additives to make them highly palatable. The widespread consumption of these foods and […] Continue reading -> Are The Three Pandemic Negotiations Bringing a Safer World Closer? 31/07/2023 Kerry Cullinan While July saw a crush of global pandemic-related meetings – some joint and some clashing – to accommodate tight schedules and northern summer holidays, achieving a pandemic-proof world is still a long way off. The two pandemic negotiations underway at the World Health Organization (WHO) have held individual and joint meetings over the past few […] Continue reading -> While Anti-Smoking Policies Cover 70% of Global Population, Taxation is Under-Utilised 31/07/2023 Elaine Ruth Fletcher Some 5.6 billion people – 71% of the world’s population – are now covered by at least one tobacco protection policy adopted by their national governments, according to a new World Health Organization (WHO) report published today. That is five times more people than were protected in 2007, when the comprehensive set of anti-smoking policies, […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> A ‘New Era’: Drug Slows Alzheimer’s Progression By One-Third 18/07/2023 Stefan Anderson For the second time this year, a new drug showed that the cognitive decline caused by Alzheimer’s disease – the leading cause of dementia worldwide that affects an estimated 55 million people – can be slowed down. Clinical trial results for donanemab, presented to the Alzheimer’s Association International Conference on Monday, showed the antibody medicine […] Continue reading -> Unite, Act, Eliminate: Mobilising Africa’s Response Against Neglected Tropical Diseases 14/07/2023 Umaro Sissoco Embaló African leaders must take the lead in the fight against Neglected Tropical Diseases, invest in their control and elimination, and foster cross-border collaboration to achieve the goal of eliminating NTDs as public health concerns by 2030. Neglected Tropical Diseases (NTDs) continue to pose a significant threat to the health and well-being of millions of people […] Continue reading -> Aspartame Linked to Liver Cancer but Evidence ‘Limited’: New Findings by International Cancer Agency 14/07/2023 Kerry Cullinan In groundbreaking new research, experts at the International Agency for Research on Cancer (IARC) have raised a cautious red flag about the artificial sweetener, aspartame, and its link to liver cancer, but stress that evidence is “limited”. IARC’s Dr Mary Schubauer-Berigan described the artificial sweetener as “possibly carcinogenic to humans” based on “limited evidence” of […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Are The Three Pandemic Negotiations Bringing a Safer World Closer? 31/07/2023 Kerry Cullinan While July saw a crush of global pandemic-related meetings – some joint and some clashing – to accommodate tight schedules and northern summer holidays, achieving a pandemic-proof world is still a long way off. The two pandemic negotiations underway at the World Health Organization (WHO) have held individual and joint meetings over the past few […] Continue reading -> While Anti-Smoking Policies Cover 70% of Global Population, Taxation is Under-Utilised 31/07/2023 Elaine Ruth Fletcher Some 5.6 billion people – 71% of the world’s population – are now covered by at least one tobacco protection policy adopted by their national governments, according to a new World Health Organization (WHO) report published today. That is five times more people than were protected in 2007, when the comprehensive set of anti-smoking policies, […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> A ‘New Era’: Drug Slows Alzheimer’s Progression By One-Third 18/07/2023 Stefan Anderson For the second time this year, a new drug showed that the cognitive decline caused by Alzheimer’s disease – the leading cause of dementia worldwide that affects an estimated 55 million people – can be slowed down. Clinical trial results for donanemab, presented to the Alzheimer’s Association International Conference on Monday, showed the antibody medicine […] Continue reading -> Unite, Act, Eliminate: Mobilising Africa’s Response Against Neglected Tropical Diseases 14/07/2023 Umaro Sissoco Embaló African leaders must take the lead in the fight against Neglected Tropical Diseases, invest in their control and elimination, and foster cross-border collaboration to achieve the goal of eliminating NTDs as public health concerns by 2030. Neglected Tropical Diseases (NTDs) continue to pose a significant threat to the health and well-being of millions of people […] Continue reading -> Aspartame Linked to Liver Cancer but Evidence ‘Limited’: New Findings by International Cancer Agency 14/07/2023 Kerry Cullinan In groundbreaking new research, experts at the International Agency for Research on Cancer (IARC) have raised a cautious red flag about the artificial sweetener, aspartame, and its link to liver cancer, but stress that evidence is “limited”. IARC’s Dr Mary Schubauer-Berigan described the artificial sweetener as “possibly carcinogenic to humans” based on “limited evidence” of […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
While Anti-Smoking Policies Cover 70% of Global Population, Taxation is Under-Utilised 31/07/2023 Elaine Ruth Fletcher Some 5.6 billion people – 71% of the world’s population – are now covered by at least one tobacco protection policy adopted by their national governments, according to a new World Health Organization (WHO) report published today. That is five times more people than were protected in 2007, when the comprehensive set of anti-smoking policies, […] Continue reading -> Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> A ‘New Era’: Drug Slows Alzheimer’s Progression By One-Third 18/07/2023 Stefan Anderson For the second time this year, a new drug showed that the cognitive decline caused by Alzheimer’s disease – the leading cause of dementia worldwide that affects an estimated 55 million people – can be slowed down. Clinical trial results for donanemab, presented to the Alzheimer’s Association International Conference on Monday, showed the antibody medicine […] Continue reading -> Unite, Act, Eliminate: Mobilising Africa’s Response Against Neglected Tropical Diseases 14/07/2023 Umaro Sissoco Embaló African leaders must take the lead in the fight against Neglected Tropical Diseases, invest in their control and elimination, and foster cross-border collaboration to achieve the goal of eliminating NTDs as public health concerns by 2030. Neglected Tropical Diseases (NTDs) continue to pose a significant threat to the health and well-being of millions of people […] Continue reading -> Aspartame Linked to Liver Cancer but Evidence ‘Limited’: New Findings by International Cancer Agency 14/07/2023 Kerry Cullinan In groundbreaking new research, experts at the International Agency for Research on Cancer (IARC) have raised a cautious red flag about the artificial sweetener, aspartame, and its link to liver cancer, but stress that evidence is “limited”. IARC’s Dr Mary Schubauer-Berigan described the artificial sweetener as “possibly carcinogenic to humans” based on “limited evidence” of […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Equitable Drug Access and Finance Are Looming Issues in Talks on International Health Regulations 28/07/2023 Elaine Ruth Fletcher The thorny and unresolved issues of how to incorporate health equity measures and supportive finance for low and middle income countries into revisions of the WHO International Health Regulations (IHR), are set to be two key items on the agenda of an IHR negotiating body when talks resume again in early October. This was one […] Continue reading -> Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> A ‘New Era’: Drug Slows Alzheimer’s Progression By One-Third 18/07/2023 Stefan Anderson For the second time this year, a new drug showed that the cognitive decline caused by Alzheimer’s disease – the leading cause of dementia worldwide that affects an estimated 55 million people – can be slowed down. Clinical trial results for donanemab, presented to the Alzheimer’s Association International Conference on Monday, showed the antibody medicine […] Continue reading -> Unite, Act, Eliminate: Mobilising Africa’s Response Against Neglected Tropical Diseases 14/07/2023 Umaro Sissoco Embaló African leaders must take the lead in the fight against Neglected Tropical Diseases, invest in their control and elimination, and foster cross-border collaboration to achieve the goal of eliminating NTDs as public health concerns by 2030. Neglected Tropical Diseases (NTDs) continue to pose a significant threat to the health and well-being of millions of people […] Continue reading -> Aspartame Linked to Liver Cancer but Evidence ‘Limited’: New Findings by International Cancer Agency 14/07/2023 Kerry Cullinan In groundbreaking new research, experts at the International Agency for Research on Cancer (IARC) have raised a cautious red flag about the artificial sweetener, aspartame, and its link to liver cancer, but stress that evidence is “limited”. IARC’s Dr Mary Schubauer-Berigan described the artificial sweetener as “possibly carcinogenic to humans” based on “limited evidence” of […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Brazil’s Success in Preventing Malaria Relapse Using New Single-Dose Treatment 20/07/2023 Marcus Lacerda & Elodie Jambert Brazil is the first country in the world to introduce tafenoquine, the first new single-dose treatment for P. vivax malaria developed in 70 years, in its public health system. Raquel da Silva has lived in Manaus in Brazil’s Amazonas State since her childhood. Today she shares her home on the banks of the Rio Negro […] Continue reading -> A ‘New Era’: Drug Slows Alzheimer’s Progression By One-Third 18/07/2023 Stefan Anderson For the second time this year, a new drug showed that the cognitive decline caused by Alzheimer’s disease – the leading cause of dementia worldwide that affects an estimated 55 million people – can be slowed down. Clinical trial results for donanemab, presented to the Alzheimer’s Association International Conference on Monday, showed the antibody medicine […] Continue reading -> Unite, Act, Eliminate: Mobilising Africa’s Response Against Neglected Tropical Diseases 14/07/2023 Umaro Sissoco Embaló African leaders must take the lead in the fight against Neglected Tropical Diseases, invest in their control and elimination, and foster cross-border collaboration to achieve the goal of eliminating NTDs as public health concerns by 2030. Neglected Tropical Diseases (NTDs) continue to pose a significant threat to the health and well-being of millions of people […] Continue reading -> Aspartame Linked to Liver Cancer but Evidence ‘Limited’: New Findings by International Cancer Agency 14/07/2023 Kerry Cullinan In groundbreaking new research, experts at the International Agency for Research on Cancer (IARC) have raised a cautious red flag about the artificial sweetener, aspartame, and its link to liver cancer, but stress that evidence is “limited”. IARC’s Dr Mary Schubauer-Berigan described the artificial sweetener as “possibly carcinogenic to humans” based on “limited evidence” of […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A ‘New Era’: Drug Slows Alzheimer’s Progression By One-Third 18/07/2023 Stefan Anderson For the second time this year, a new drug showed that the cognitive decline caused by Alzheimer’s disease – the leading cause of dementia worldwide that affects an estimated 55 million people – can be slowed down. Clinical trial results for donanemab, presented to the Alzheimer’s Association International Conference on Monday, showed the antibody medicine […] Continue reading -> Unite, Act, Eliminate: Mobilising Africa’s Response Against Neglected Tropical Diseases 14/07/2023 Umaro Sissoco Embaló African leaders must take the lead in the fight against Neglected Tropical Diseases, invest in their control and elimination, and foster cross-border collaboration to achieve the goal of eliminating NTDs as public health concerns by 2030. Neglected Tropical Diseases (NTDs) continue to pose a significant threat to the health and well-being of millions of people […] Continue reading -> Aspartame Linked to Liver Cancer but Evidence ‘Limited’: New Findings by International Cancer Agency 14/07/2023 Kerry Cullinan In groundbreaking new research, experts at the International Agency for Research on Cancer (IARC) have raised a cautious red flag about the artificial sweetener, aspartame, and its link to liver cancer, but stress that evidence is “limited”. IARC’s Dr Mary Schubauer-Berigan described the artificial sweetener as “possibly carcinogenic to humans” based on “limited evidence” of […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Unite, Act, Eliminate: Mobilising Africa’s Response Against Neglected Tropical Diseases 14/07/2023 Umaro Sissoco Embaló African leaders must take the lead in the fight against Neglected Tropical Diseases, invest in their control and elimination, and foster cross-border collaboration to achieve the goal of eliminating NTDs as public health concerns by 2030. Neglected Tropical Diseases (NTDs) continue to pose a significant threat to the health and well-being of millions of people […] Continue reading -> Aspartame Linked to Liver Cancer but Evidence ‘Limited’: New Findings by International Cancer Agency 14/07/2023 Kerry Cullinan In groundbreaking new research, experts at the International Agency for Research on Cancer (IARC) have raised a cautious red flag about the artificial sweetener, aspartame, and its link to liver cancer, but stress that evidence is “limited”. IARC’s Dr Mary Schubauer-Berigan described the artificial sweetener as “possibly carcinogenic to humans” based on “limited evidence” of […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Aspartame Linked to Liver Cancer but Evidence ‘Limited’: New Findings by International Cancer Agency 14/07/2023 Kerry Cullinan In groundbreaking new research, experts at the International Agency for Research on Cancer (IARC) have raised a cautious red flag about the artificial sweetener, aspartame, and its link to liver cancer, but stress that evidence is “limited”. IARC’s Dr Mary Schubauer-Berigan described the artificial sweetener as “possibly carcinogenic to humans” based on “limited evidence” of […] Continue reading -> COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
COVID Highlighted Problems in Accessing Medicine for Non-Communicable Diseases – But They Can be Fixed 12/07/2023 Bente Mikkelsen The COVID-19 pandemic exacerbated patients’ difficulties in accessing medication for non-communicable diseases (NCDs), but there is a range of measures countries can take to mitigate this – and a pandemic accord could address some of the structural weaknesses. COVID-19 had a disproportionate and far-reaching impact on people living with NCDs. Not only were they more […] Continue reading -> Posts navigation Older postsNewer posts